Stock Price
5.50
Daily Change
0.08 1.48%
Monthly
7.63%
Yearly
16.53%
Q1 Forecast
4.90

Silence Therapeutics reported $2.77M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Autolus Therapeutics Ltd USD 24.91M 6.96M Jun/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Silence Therapeutics USD 2.77M 136K Sep/2024